Skip to main content
OpenTrials

Clinical trial condition

Hodgkin Lymphoma

Explore clinical trials studying Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

235 public trials 61 recruiting studies
Refine in advanced search Browse all conditions

Hodgkin Lymphoma trial results

Active, Not Recruiting

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma

NCT00846742

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • Packard Children's Hospital, Stanford University Palo Alto, California, United States
  • Rady Children's Hospital- San Diego San Diego, California, United States
  • Children's Hospital of Illinois at OSF St. Francis Medical Center Peoria, Illinois, United States
  • Maine Children's Cancer Program (MCCP) Scarborough, Maine, United States
View Trial Details
Active, Not Recruiting

Tislelizumab, Gemcitabine and Cisplatin for R/R Hodgkin Lymphoma Followed by Tislelizumab Consolidation in Patients in Metabolic Complete Remission

NCT05502250

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • BE-Bruxelles-STLUC Brussels, Belgium
  • DK-Aarhus N-AUH Aarhus, Denmark
  • DK-Copenhagen-RIGSHOSPITALET Copenhagen, Denmark
  • DK-Odense-OUH Odense, Denmark
View all 15 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)

NCT03407144

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • Children's Hospital of Alabama ( Site 0023) Birmingham, Alabama, United States
  • Phoenix Childrens Hospital ( Site 0034) Phoenix, Arizona, United States
  • Arkansas Children's Hospital ( Site 0046) Little Rock, Arkansas, United States
  • Kaiser - Orange County ( Site 0084) Anaheim, California, United States
View all 93 locations
View Trial Details
Active, Not Recruiting

A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)

NCT03033914

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Hackensack Meridian Health Hackensack, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
View Trial Details

Related conditions